Year/Author Test Article Results
2012 MihyeJeong Oral administration with 5% Paecilomycessinclairii for 13 weeks in rats It had no significant effect on serum levels of BUN and creatinine.
1993 Zhu-An Chen Oral administration with extracts of C. cicadae or Paecilomyces cicadae (60 g/kg) in mice It had no significant effect on mortality 72 h following treatment, with a LD50 of 14.2 ± 2.1 g/kg and 12.5 ± 2.1 g/kg.
2004 Jie-Min Song Oral administration with C. cicadae for 7 days in mice The maximum tolerable dose of C. cicadae was 80 g/kg, which was 444 times higher than that the clinically recommended dose.
2009 Seung Jun Kwack Oral administration with extracts of C. cicadae or Paecilomyces cicadae for 14 days in mice It had no significant effect on mortality, with a LD50 of 5 g/kg. There were no other abnormalities except for decreased thymus weight presented in male mice.
2013 Shu-HsingYeh Feed adding 5% C. cicadae mycelium produced using artificial fermentation method No toxic effect was observed after 28 days of feeding experiment in pig.
2015 Jui-Hsia Hsu C. cicadae mycelium No cytotoxic or mutagenic potential in the Ames test at levels of up to 5 mg/plate. In the chromosomal aberration test, C. cicadae mycelium also showed no genetic toxicology when exposed to the CHO-K1 cells in the presence and absence of a metabolic activation system derived from rat liver S9 mix at levels of up to 5 mg/ml. Moreover, no C. cicadae mycelium-related increase was observed in the bone marrow cell micronucleus test at levels of up to 5,000 mg/kg BW. Additionally, C. cicadae mycelium did not interfere with mouse bone marrow hematopoiesis in the proportion of polychromatic erythrocytes in the peripheral blood.
2015 Yen-Lien Chen Oral administration with C. cicadae for 90 days in rats No toxic effect was observed and the no-observed-adverse-effect-level (NOAEL) of C. cicadae whole broth is greater than 2000 mg/kg (as 114.3 times of recommended daily dosage for human) for rats.
Table 3: Food Safety Evaluation Tests of C. cicadae.